Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation

International Journal of Medical Microbiology

Volumn 301, Issue 2, 2011, Pages 140-149

  Pero, Raffaela ^a   Peluso, Silvia ^a   Angrisano, Tiziana ^a   Tuccillo, Concetta ^a   Sacchetti, Silvana ^a,b   Keller, Simona ^a   Tomaiuolo, Rossella ^b   Bruni, Carmelo B ^a   Lembo, Francesca ^c   Chiariotti, Lorenzo ^a,c  

^a Dipartimento di Biologia e Patologia Cellulare e Molecolare L Califano   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chromatin modifications; COX 2; DNA methylation; Gastric cells; Helicobacter pylori

Indexed keywords

CYCLOOXYGENASE 2; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; NONHUMAN;

CELL LINE; CHROMATIN; CYCLOOXYGENASE 2; DNA METHYLATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HELICOBACTER PYLORI; HISTONE DEACETYLASES; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMANS; METHYLATION;

EID: 78751580387     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.06.009     Document Type: Article

References (47)

1. Aras R.A., Lee Y., Kim S.K., Israel D., Peek R.M., Blaser M.J. Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype. J. Infect. Dis. 2003, 188:486-496.
2. Atherton J.C., Cao P., Peek R.M., Tummuru M.K., Blaser M.J., Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 1995, 30:17771-17777.
3. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
4. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
5. Buecher B., Bouancheau D., Broquet A., Bezieau S., Denis M.G., Bonnet C., Heymann M.F., Jarry A., Galmiche J.P., Blottière H.M. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines. Anticancer Res. 2005, 25:225-233.
6. Chan C., Li L., McCall C.E., Yoza B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J. Immunol. 2005, 1:461-468.
7. Chang Y.J., Wu M.S., Lin J.T., Sheu B.S., Muta T., Inoue H., Chen C.C. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 2004, 66:1465-1477.
8. Cover T.L., Dooley C.P., Blaser M.J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 1990, 58:603-610.
9. de Maat M.F., van de Velde C.J., Umetani N., de Heer P., Putter H., van Hoesel A.Q., Meijer G.A., van Grieken N.C., Kuppen P.J., Bilchik A.J., Tollenaar R.A., Hoon D.S. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J. Clin. Oncol. 2007, 31:4887-4894.
10. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 4:1183-1188.
11. Ehrich M., Nelson M.R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., Cantor C.R., Field J.K., van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2005, 44:15785-15790.
12. El Gazzar M., Yoza B.K., Hu J.Y., Cousart S.L., McCall C.E. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J. Biol. Chem. 2007, 37:26857-26864.
13. Erkisi M., Colakoglu S., Köksal F., Tuncer I., Burgut R., Karaköse H., Doran F., Zorludemir S. Relationship of Helicobacter pylori infection to several malignant and non-malignant gastrointestinal diseases. J. Exp. Clin. Cancer Res. 1997, 3:289-293.
14. Franco A.T., Johnston E., Krishna U., Yamaoka Y., Israel D.A., Nagy T.A., Wroblewski L.E., Piazuelo M.B., Correa P., Peek R.M. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008, 2:379-387.
15. Fu S., Ramanujam K.S., Wong A., Fantry G.T., Drachenberg C.B., James S.P., Meltzer S.J., Wilson K.T. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999, 116:1319-1329.
16. Gerhard M., Lehn N., Neumayer N., Borén T., Rad R., Schepp W., Miehlke S., Classen M., Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12778-12783.
17. Hamon M.A., Cossart P. Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 2008, 2:100-109.
18. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
19. Kangaspeska S., Stride B., Métivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
20. Komoto K., Haruma K., Kamada T., Tanaka S., Yoshihara M., Sumii K., Kajiyama G., Talley N.J. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am. J. Gastroenterol. 1998, 93:1271-1276.
21. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
22. Le'Negrate G., Ricci V., Hofman V., Mograbi B., Hofman P., Rossi B. Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect. Immun. 2001, 8:5001-5009.
23. Lim H.Y., Joo H.J., Choi J.H., Yi J.W., Yang M.S., Cho D.Y., Kim H.S., Nam D.K., Lee K.B., Kim H.C. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res. 2000, 6:519-525.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006, 12:989-995.
26. Métivier R., Gallais R., Tiffoche C., Le Péron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., Benes V., Jeltsch A., Gannon F., Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
27. Motoyama T., Hojo H., Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. 1986, 36:65-83.
28. Nie M., Pang L., Inoue H., Knox A.J. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol. Cell Biol. 2003, 24:9233-9244.
29. Park G.Y., Joo M., Pedchenko T., Blackwell T.S., Christman J.W. Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 5:L956-962.
30. Parsonnet J., Vandersteen D., Goates J., Sibley R.K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J. Natl. Cancer Inst. 1991, 9:640-643.
31. Pathak S.K., Basu S., Bhattacharyya A., Pathak S., Banerjee A., Basu J., Kundu M. TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J. Immunol. 2006, 11:7950-7958.
32. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
33. Perri F., Cotugno R., Piepoli A., Merla A., Quitadamo M., Gentile A., Pilotto A., Annese V., Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am. J. Gastroenterol. 2007, 7:1361-1371.
34. Romano M., Razandi M., Sekhon S., Krause W.J., Ivey K.J. Human cell line for study of damage to gastric epithelial cells in vitro. J. Lab. Clin. Med. 1988, 111:430-440.
35. 2 synthesis in MKN 28 gastric mucosal cells in vitro. J. Biol. Chem. 1998, 273:28560-28563.
36. Saccani S., Pantano S., Natoli G. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 2002, 3:69-75.
37. Saukkonen K., Rintahaka J., Sivula A., Buskens C.J., Van Rees B.P., Rio M.C., Haglund C., Van Lanschot J.J., Offerhaus G.J., Ristimaki A. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003, 10:915-925.
38. Suganuma M., Kuzuhara T., Yamaguchi K., Fujiki H. Carcinogenic role of tumor necrosis factor-α inducing protein of Helicobacter pylori in human stomach. J. Biochem. Mol. Biol. 2006, 39:1-8.
39. Takahashi S., Fujita T., Yamamoto A. Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 4:791-798.
40. Turner B.M. Defining an epigenetic code. Nat. Cell Biol. 2007, 9:2-6.
41. van Doorn L.J., Figueiredo C., Sanna R., Plaisier A., Schneeberger P., de Boer W., Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998, 115:58-66.
42. Viré E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439:8741-8744.
43. Wang C.C., Wu M.S., Wang H.H., Wang H.P., Lee W.C., Shun C.T., Lin J.T. Helicobacter pylori infection and age on the development of intestinal metaplasia - a multiple logistic regression analysis. Hepatogastroenterology 1998, 45:2234-2237.
44. Watanabe T., Tada M., Nagai H., Sasaki S., Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998, 115:642-648.
45. Weinmann A.S., Mitchell D.M., Sanjabi S., Bradley M.N., Hoffmann A., Liou H.C., Smale S.T. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2001, 2:51-57.
46. You W.C., Zhang L., Gail M.H., Chang Y.S., Liu W.D., Ma J.L., Li J.Y., Jin M.L., Hu Y.R., Yang C.S., Blaser M.J., Correa P., Blot W.J., Fraumeni J.F., Xu G.W. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl. Cancer Inst. 2000, 19:1607-1612.
47. Zheng Q., Chen X.Y., Shi Y., Xiao S.D. Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori. J. Gastroenterol. Hepatol. 2004, 19:1192-1198.